๐ด $DFTX โ Roberts Brandi, Chief Financial Officer
SOLD: 3,377 shares @ $36.57
Total: $123K
Filed Sep 24, 2026 ยท 8:00pm ET
๐ History & trend โ https://www.formdelta.com/ticker/DFTX

๐ด $DFTX โ Roberts Brandi, Chief Financial Officer
SOLD: 3,377 shares @ $36.57
Total: $123K
Filed Sep 24, 2026 ยท 8:00pm ET
๐ History & trend โ https://www.formdelta.com/ticker/DFTX
๐ด $DFTX โ Sullivan Mark, Chief Legal Officer
SOLD: 14,051 shares @ $36.57
Total: $514K
Filed Sep 24, 2026 ยท 8:00pm ET
๐ History & trend โ https://www.formdelta.com/ticker/DFTX
๐ด $DFTX โ Wiley Matthew T., Chief Commercial Officer
SOLD: 3,097 shares @ $36.57
Total: $113K
Filed Sep 24, 2026 ยท 8:00pm ET
๐ History & trend โ https://www.formdelta.com/ticker/DFTX
๐ด $DFTX โ Barrow Robert, Chief Executive Officer
SOLD: 31,550 shares @ $36.57
Total: $1.2M
Filed Sep 24, 2026 ยท 8:00pm ET
๐ History & trend โ https://www.formdelta.com/ticker/DFTX
๐ด $DFTX โ Karlin Daniel, Chief Medical Officer
SOLD: 10,853 shares @ $36.57
Total: $397K
Filed Sep 24, 2026 ยท 8:00pm ET
๐ History & trend โ https://www.formdelta.com/ticker/DFTX
๐ $DFTX 10-Q โ what changed
MD&A now says: "Management's Discussion and Analysis of Financial Condition and Results of Operations 19"
๐ Full redline โ https://www.formdelta.com/ticker/DFTX
#DFTX Definium Therapeutics Announces New Employee Inducement Grants
In this trial, called Panorama, patients taking DT120 saw significantly greater anxiety relief than those on placebo after 12 weeks, with improvement starting as early as day two.
#DFTX #Definium #DT120 #MentalHealth #Psychedelics #ClinicalTrial
๐จ JUST IN: $DFTX
Definium gets second FDA Breakthrough Therapy designation for DT120 in MDD
#SEC #stocks #investing #DFTX #Regulatory
๐ secwatch.observer